In patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms

被引：1
|
作者：
Holbrook, Anne [1 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
来源：
ANNALS OF INTERNAL MEDICINE | 2018年 / 168卷 / 04期
关键词：
RISK;
D O I：
10.7326/ACPJC-2018-168-4-023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：JC23 / JC23
页数：1
相关论文
共 50 条
  • [1] CAN WE PREDICT THE RISK FACTORS FOR SWITCHING IN THE FIRST YEAR OF THERAPY WITH BDMARD IN PATIENTS WITH RHEUMATOID ARTHRITIS?
    Martins, A.
    Oliveira, D. Santos
    Nicolau, R.
    Martins-Rocha, T.
    Bernardo, A.
    Pimenta, S.
    Bernardes, M.
    Costa, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1394 - 1395
  • [2] Fatigue Levels Are Not Associated with Inflammatory Activity, but with Subjective Outcomes: Results from a Longitudinal Study of Patients with Rheumatoid Arthritis Initiating bDMARD Therapy
    Hammer, Hilde
    Michelsen, Brigitte
    Sexton, Joe
    Provan, Sella
    Uhlig, Till
    Kvien, Tore
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] Filgotinib for bDMARD-refractory rheumatoid arthritis
    Clark, Anna
    [J]. LANCET RHEUMATOLOGY, 2019, 1 (01): : E11 - E11
  • [4] PALMAR FASCIITIS AND ARTHRITIS ASSOCIATED WITH MALIGNANT NEOPLASMS
    PFINSGRAFF, J
    BUCKINGHAM, RB
    KEISTER, SR
    BRERETON, WF
    KILLIAN, PJ
    [J]. CLINICAL RESEARCH, 1984, 32 (03): : A722 - A722
  • [5] Hematologic Malignant neoplasms after drug exposure in rheumatoid arthritis
    Bernatsky, Sasha
    Clarke, Ann E.
    Suissa, Samy
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (04) : 378 - 381
  • [6] COMORBIDITIES IN RHEUMATOID ARTHRITIS ASSOCIATED WITH DMARD VERSUS BDMARD IN SANTO DOMINGO, DOMINICAN REPUBLIC
    Vasquez, Angelo Alberto Cornelio
    Mora, Teresandris Polanco
    De Heyaime, Jennifer Santana Peralta
    Cruz, Yamilet
    Bautista, Edral Rodriguez
    Lorie, Tirso Valdez
    Imuis, Roberto Munoz
    Feriz, Rafael Alba
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S85 - S85
  • [7] Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis?
    Martins, Ana
    Pimenta, Sofia
    Oliveira, Daniela
    Nicolau, Rafaela
    Bernardo, Alexandra
    Rocha, Teresa Martins
    Costa, Lucia
    Bernardes, Miguel
    [J]. REUMATOLOGIA CLINICA, 2024, 20 (07): : 380 - 385
  • [8] MALIGNANT LYMPHOMA ASSOCIATED WITH RHEUMATOID-ARTHRITIS
    KATONGOLEMBIDDE, E
    OLWENY, CLM
    KANYEREZI, BR
    OWOR, R
    [J]. EAST AFRICAN MEDICAL JOURNAL, 1976, 53 (08) : 503 - 503
  • [9] ONE YEAR EXPERIENCE OF A BDMARD SPACING PROTOCOL IN REAL LIFE RHEUMATOID ARTHRITIS PATIENTS
    Todoerti, M.
    Monti, S.
    Grosso, V.
    De Nard, F.
    Breda, S.
    Chiapparoli, I.
    Caporali, R.
    Montecucco, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 975 - 975
  • [10] THE RISK FACTORS FOR SEVERE EXACERBATION OF INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS DURING BDMARD THERAPY
    Tanaka, A.
    Kurasawa, K.
    Miyao, T.
    Takamura, Y.
    Yamazaki, R.
    Arai, S.
    Owada, T.
    Maezawa, R.
    Arima, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 926 - 926
12345